HRT Financial’s ProMIS Neurosciences PMN Stock Holding History

HRT Financial’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,722	Closed	-$28K	–	3839
2025 Q3	$28K	Buy	+2,722	New	+$37.7K	﹤0.01%	2670

Other funds holding PMN

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DEM

Disciplined Equity Management Neptune Beach, Florida $199M AUM 20.69% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HRT Financial's PMN Position: Q4 2025 in Review

HRT Financial sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 2,722 shares — an estimated $28K sold.

HRT Financial first reported a position in PMN in Q3 2025 and held it in 1 quarter. The position peaked at $28K in Q3 2025. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

HRT Financial reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 2,722 ProMIS Neurosciences shares in Q4 2025, an estimated $28K.
HRT Financial first reported a position in ProMIS Neurosciences in Q3 2025 and held it in 1 quarter.
HRT Financial's ProMIS Neurosciences position peaked at $28K in Q3 2025.
9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.